Effect of Aerobic Exercise Program on Blood Glucose Level and Quality of Life in Pre-diabetic Overweight/Obese Adolescents

January 1, 2025 updated by: Marina Nabil Samaan Meseha, Cairo University

PURPOSE:

The study aims to:

Investigate the effect of the designed aerobic exercise program on the blood glucose level (fasting blood glucose and HbA1C) in overweight/ obese pre-diabetic adolescents.

2) Investigate the effect of the designed aerobic exercise program on the BMI, aerobic capacity, and waist circumference of the participant before and after the designed aerobic exercise program.

3) Investigate the effect of the designed aerobic exercise program on the quality of life in overweight/ obese pre-diabetic adolescents.

4) Compare the effect of the diet program only and the diet with a designed aerobic exercise program on the blood glucose level (FBG, HbA1C) and the quality of life of the participants.

BACKGROUND:

Obesity is defined as a common chronic disorder of excessive body fat. It has become a global epidemic that is present not only in the industrialized world but also in many developing and even underdeveloped countries (Hans, 2017).

Overweight children and adolescents often suffer from symptoms of depression and anxiety, poor self-esteem, and social stigma. These psychological aspects complicate global care and affect the quality of life (QOL). The overall QOL score was lower in the overweight and obese groups compared with the normal-weight groups in all the clinical population studies. The published results also indicate that impairment in QOL worsens with a degree of obesity (Marie et al., 2014).

HYPOTHESES:

There will be no significant difference effect between the diet program only and diet program with a designed aerobic exercise program on blood glucose levels and QOL in overweight/ obese prediabetic adolescents.

RESEARCH QUESTION:

Does the designed aerobic exercise influence the blood glucose level and the quality of life in pre-diabetic overweight/obese adolescents?

Study Overview

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Giza, Egypt
        • Faculty of physical therapy, Cairo University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusive criteria:

The participants will be selected according to the following criteria:

  1. Their ages range from 12 to 18 years old.
  2. They will be overweight and obese according to BMI charts of CDC:

    • Overweight is 85 percentiles to less than the 95 percentile,
    • Obesity is 95 percentile or greater) (CDC, 2022).
  3. They will be prediabetic according to CDC, USPSTF (2022):

    • HbA1c level of will be 5.7% to 6.4%,
    • A fasting plasma glucose level will be 100 to 125 mg/dL.
  4. Their waist circumference percentiles will be in the area outside of the normal WC curve according to WHO, normal children and adolescents are in the area under the curve (AUC): 0.69 for boys; 0.63 for girls for normal adolescents) (Bo xi et al., 2020)
  5. They will be able to follow instructions during evaluation and treatment.

Exclusive criteria:

Any adolescent with the following criteria will be directly excluded from the evaluation for the consistency of the sample and statistically obtained results:

  1. Cardiovascular diseases,
  2. Diabetes Mellitus,
  3. Morbid obesity more than 120% of the 95 percentile or greater or 35 kg/m or greater.
  4. Hearing or visual impairments.
  5. Any orthopedic deformities in upper limb or lower limb.
  6. Uncontrolled seizures.
  7. Receiving any special medications.
  8. Participated regularly in sportive activities.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: study group, overweight and obese adolescents with prediabetes
aerobic exercise program for 3 months with nutritional health awearness sessions
lifestyle changes and nutritional awareness sessions for 3 months twice a week for participants and their parents
Active Comparator: control group, overweight and obese adolescents with prediabetes
lifestyle changes and nutritional awareness sessions for 3 months twice a week for participants and their parents

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
changed HbA1c
Time Frame: 3 months
3 months
changed BMI
Time Frame: 3 months
3 months
changed Quality of life questionnaire results
Time Frame: 3 months
3 months

Secondary Outcome Measures

Outcome Measure
Time Frame
changed waist circumference
Time Frame: 3 months
3 months
changed fasting blood glucose level
Time Frame: 3 months
3 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 10, 2022

Primary Completion (Actual)

February 4, 2023

Study Completion (Actual)

August 20, 2023

Study Registration Dates

First Submitted

December 14, 2024

First Submitted That Met QC Criteria

January 1, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 1, 2025

Last Verified

December 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe